Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
1(8%)
Results Posted
13%(1 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
11
92%
Ph phase_2
1
8%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(8)
Terminated(1)
Other(1)

Detailed Status

Completed8
Recruiting1
Not yet recruiting1
Suspended1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
88.9%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (8.3%)
N/A11 (91.7%)

Trials by Status

recruiting18%
completed867%
not_yet_recruiting18%
suspended18%
terminated18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12